Neuromyelitis optica spectrum disorder (NMOSD) is a rare, relapsing-remitting
neuroinflammatory disorder of the central nervous system (CNS) usually associated with …

Abstract Purpose of Review To review the pathophysiology, presentation, and treatment of
neuromyelitis optica spectrum disorder (NMOSD) and its association with systemic lupus …

Methotrexate (MTX) is a chemotherapeutic agent that can cause a range of toxic side effects
including gastrointestinal damage, hepatotoxicity, myelosuppression, and nephrotoxicity …

Here, in Part II of a duology on the characterization and potential treatment for COVID-19, we
characterize the application of an innovative treatment regimen for the prevention of the …

Methotrexate (MTX) is used in the treatment of certain types of cancers and chronic
inflammatory illnesses, although the clinical use of MTX is limited due to its adverse effects …

Methotrexate (MTX) is a widely used therapeutic agent for the treatment of cancer and
autoimmune diseases. However, its efficacy is often limited by adverse effects, such as …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has produced a world-wide
collapse of social and economic infrastructure, as well as constrained our freedom of …

Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disease (CTD),
the main features of which are multiple serum autoantibodies and extensive involvement of …

The first description of neuromyelitis optica by Eugène Devic and Fernand Gault dates back
to the 19th century, but only the discovery of aquaporin-4 autoantibodies in a major subset of …

Background Evidence for central nervous system involvement in primary Sjögren's
syndrome (pSS) patients is controversial and extremely limited. We aimed to describe the …